Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma
Journal of Cancer Research & Clinical Oncology, 06/12/2012
Jin Y et al. – Cisplatin+5–fluororacil (PF), paclitaxel+cisplatin (TP), gemcitabine+cisplain (GP) are all effective regimens as the first–line chemotherapy for metastatic nasopharyngeal carcinoma (NPC), which can be well tolerated. Over four cycles of chemotherapy are recommended under no contraindication. Patients should transfer to the second–line regimen after the treatment failure of the first–line chemotherapy.